# Aminoglycoside Monitoring

> Aminoglycoside monitoring for NEET-PG Pharmacology: extended interval dosing, gentamicin amikacin peak and trough targets, nephrotoxicity and ototoxicity.

- Canonical URL: https://prepelephant.com/topics/neet-pg/pharmacology/aminoglycoside-monitoring
- Exam / course: NEET-PG · Subject: Pharmacology
- Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team
- First published: 2026-10-02
- Last updated: 2026-10-02
- How to cite: "Aminoglycoside Monitoring", PrepElephant, https://prepelephant.com/topics/neet-pg/pharmacology/aminoglycoside-monitoring

## Direct answer

Gentamicin given once daily kills better and poisons less than the same drug split into three doses — aminoglycosides are concentration-dependent killers with a substantial post-antibiotic effect, so extended-interval dosing (gentamicin or tobramycin 5-7 mg/kg, amikacin 15-20 mg/kg every 24 hours) maximises bacterial kill while the drug-free trough lets renal cortex exposure recover. Traditional three-times-daily regimens, when still used, target gentamicin peaks of 4-10 mcg/mL with troughs below 2, and amikacin peaks 20-30 with troughs below 5-8. Two toxicities set the monitoring duty: non-oliguric nephrotoxicity in 5-10 per cent, usually after five or more days and largely reversible, and irreversible cochlear ototoxicity, which no level predicts — renal indices are watched daily, hearing clinically. Risk multipliers are age, dehydration, cirrhosis, concurrent vancomycin, loop diuretics and pre-existing kidney disease.

## What you must remember

- **Extended-interval dosing:** gentamicin/tobramycin 5-7 mg/kg IV once daily, amikacin 15-20 mg/kg once daily — the once-daily logic (high peak to MIC ratio plus post-antibiotic effect) is a standing viva.
- **Traditional targets when used:** gentamicin peak 4-10 mcg/mL and trough below 2; amikacin peak 20-30 mcg/mL and trough below 5-8 mcg/mL; troughs drawn just before the fourth dose at steady state.
- **Extended-interval check:** a level 6-14 hours after the dose, read against a nomogram (Hartford-style) to decide the next interval; an undetectable 24-hour trough is the goal in straightforward infections.
- **Nephrotoxicity profile:** 5-10 per cent, non-oliguric, proximal tubular injury (raised creatinine after 5-7 days), mostly reversible on stopping; risk rises with duration, dehydration, loop diuretics, vancomycin and contrast.
- **Ototoxicity profile:** irreversible cochlear (high-frequency hearing loss) and vestibular damage, cumulative, not predicted by plasma levels — avoid pairing with loop diuretics, warn every patient.
- **Synergy duty:** enterococcal endocarditis needs gentamicin 1 mg/kg every 8 hours (or every 12 hours in the elderly) alongside a beta-lactam, with troughs below 1 — a dosing exception that exams love.
- **Indian context:** amikacin is also a second-line tuberculosis drug under the National TB Elimination Programme's drug-resistant regimens, where audiometry and monthly creatinine are programme-mandated; cheap generic gentamicin is used nationwide, so monitoring discipline — not availability — is the rate limiter.

## Dosing a septic patient through day one

Admit a 45-year-old, 70 kg man with urosepsis and normal renal function. Prescribe gentamicin 420 mg (6 mg/kg) IV over 30-60 minutes as a single daily dose alongside a beta-lactam. Draw a level 6-14 hours later — say 2.2 mcg/mL at 8 hours — plot it on the nomogram, and the 24-hour interval is confirmed; daily creatinine and urine output follow. Had the 8-hour level been high, the nomogram would stretch the interval to 36 or 48 hours rather than shrink the dose, preserving peak efficacy while clearing the trough. Contrast the exceptions that force traditional dosing: enterococcal endocarditis synergy (gentamicin 1 mg/kg every 8 hours, trough below 1), burns and pregnancy (altered volumes of distribution), and dialysis (dosing after sessions with post-dialysis levels).

By day five, a creatinine creeping from 0.9 to 1.4 signals the renal signal — check trough (detectable at 24 hours means accumulation), extend the interval, and reconsider whether the beta-lactam can finish the job alone, since aminoglycosides shine in the first 3-5 days of severe sepsis and add toxicity thereafter.

## Where students slip on this class

The classic slip is explaining once-daily dosing as "less total drug" — the daily dose is the same or higher; what changes is the concentration-time shape and the saturable renal cortical uptake that makes troughs the toxic window. Second, trough misuse: a random mid-interval level answers nothing; timing (just before a steady-state dose, or the fixed 6-14 hour post-dose sample) is the whole test. Third, ototoxicity complacency — students monitor creatinine and forget that the ear has no early-warning blood test, so clinical screening (tinnitus, imbalance, high-frequency loss) is the only vigilance available; neomycin, the most nephrotoxic and ototoxic member, survives only as topical/oral gut decontamination, a matching-question staple. Indian exam flavour: streptomycin's historic identity (the first antitubercular, vestibular toxicity, avoided in pregnancy) and amikacin's role in multidrug-resistant TB regimens tie this class to national-programme questions rather than pure ICU lore.

## Frequently asked questions

### Why are aminoglycosides given once daily?

Concentration-dependent killing and a post-antibiotic effect mean high peaks drive efficacy, while trough-free intervals reduce renal cortical accumulation and toxicity.

### What trough targets apply to traditional gentamicin dosing?

Trough below 2 mcg/mL for gentamicin (below 5-8 for amikacin), drawn immediately before a steady-state dose, typically the fourth.

### Which aminoglycoside regimen is used for enterococcal endocarditis synergy?

Gentamicin 1 mg/kg every 8 hours with a beta-lactam, troughs kept below 1 mcg/mL, for a defined short synergy course.

### Is aminoglycoside ototoxicity reversible?

No — cochlear and vestibular damage is cumulative and irreversible, which is why clinical screening and avoiding loop diuretics matter.

### Which intrinsic organisms resist all aminoglycosides?

Proteus (variable), Serratia, Morganella and Providencia depending on species, with all aminoglycosides unreliable against intracellular and anaerobic organisms.